V体育安卓版 - Abstract
Background
Visualizing the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 and predicting future disease burdens at global, regional, and national levels can help health policymakers develop evidence-based ischemic stroke (IS) prevention and cure strategies.
"V体育安卓版" Methods
We stratify epidemiological parameters by sex, age, the World Bank’s classification of economies, and sociodemographic index (SDI) levels. We use frontier analysis to assess whether the burden of ischemic stroke (IS) in each country aligns with its level of economic development. We apply the Autoregressive Integrated Moving Average (ARIMA) model and the Bayesian age-period-cohort (BAPC) model to predict the burden of IS over the next 15 years VSports注册入口.
Results
Here we show that IS accounts for 69. 9 million prevalent cases, 7. 8 million incident cases, 3. 6 million deaths, and 70. 4 million DALYs in 2021 V体育官网入口. In men, the global DALY rate of IS increases up to age 90–94 years and then decreases; however, for women, the rate increases up to the oldest age group (≥95 years). Regionally, we find that the association between the SDI and the age-standardized DALY rate of IS starts relatively flat, with a small peak up to a sociodemographic index of about 0. 7, and then declines rapidly. Factors contributing most to the DALY rates for IS are high systolic blood pressure, high LDL cholesterol, and air pollution.
V体育ios版 - Conclusions
The disease burden of IS in medium-high SDI countries is still high, which means we could not meet the Sustainable Development Goal targets by 2030. Countries should formulate prevention and control measures suitable for their national conditions based on risk factors VSports在线直播.
Subject terms: Stroke, Stroke, Stroke
The plain language summary
Ischemic stroke (IS) occurs when blood flow to part of the brain is reduced or stopped by a blood vessel becoming blocked. We assessed death, prevalence, mortality, disability, and risk factors related to people experiencing IS between 1990 and 2021 in 204 countries and territories and predicted how these might change in the future. Globally, IS accounted for 3. 6 million deaths in 2021. Although the frequency of occurrences of IS and deaths due to IS has decreased over the past three decades, the absolute number of ISs is increasing as a result of population growth and population aging. The main risk factors include high systolic blood pressure, high low-density lipoprotein cholesterol, and air pollution. Our data could be useful at the global, regional, and national levels to help health policymakers develop evidence-based IS prevention and care strategies V体育2025版.
Liu, Xu, Zhao, Ren, Hei, Fang et al VSports. assess morbidity, prevalence, mortality, disability, risk factors, and epidemiological trends of ischemic stroke for the period 1990–2021 in 204 countries and territories. Visualizing GBD databases predicts future disease burdens at global, regional, and national levels.
Introduction
With aging populations, longer life expectancy, the impact of the COVID-19 pandemic, and changes in the prevalence of NCD risk factors, the global demographic, geographical, and temporal distribution of disease is changing rapidly. According to the GBD 2021 study, stroke is the fourth leading cause of DALYs globally (160. 4 million [95% uncertainty intervals 148. 0–171. 7]), following COVID-19 (212. 0 million [198. 0–234. 5] DALYs), ischaemic heart disease (188. 3 million [176. 7–198. 3]), and neonatal disorders (186. 3 million [162. 3–214. 9])1. Meanwhile, stroke was the third leading cause of deaths globally in 2021, but in 2010 and 1990, stroke was the second leading cause of deaths. In 1990, subarachnoid hemorrhage accounted for 9. 66% of all stroke patients, and intracerebral hemorrhage accounted for 22. 02% of all stroke patients. Ischemic stroke accounts for about 68. 32% of all stroke patients. The following conclusions are drawn from the calculation of the GBD database data over the years. In 2010, subarachnoid hemorrhage accounted for about 8. 85%, intracerebral hemorrhage for about 19. 83%, and ischemic stroke for about 71. 32%. In 2019, subarachnoid hemorrhage accounted for about 8. 46%, intracerebral hemorrhage accounted for about 17. 66%, and ischemic stroke accounted for about 73. 94%. In 2021, subarachnoid hemorrhage accounted for about 8. 24%, intracerebral hemorrhage 17. 43%, and ischemic stroke 73. 33%. IS has been the largest subtype of stroke for more than 30 years. Assessing the trend of ischemic stroke burden over time based on the latest data, the proportion of attributable risk factors, and the relationship between national economic and social development level and disease burden are necessary to guide global, regional, and national health policy formulation VSports app下载.
Ischemic stroke has been regarded as a priority target for the reduction of the burden of NCDs by the United Nations2 V体育官网. The prevention and control measures taken so far are not enough to meet the Sustainable Development Goal targets by 20302. In the context of population aging and widespread chronic disease comorbidities, prevention strategies targeting the latest IS risk factors can significantly improve the epidemiological distribution of IS. The regular and timely updating of the GBD database provides strong data support for the formulation of health strategies that are timely and in line with the latest international situation. Especially in the two years of the COVID-19 epidemic, the impact of COVID-19 on IS was still unknown.
Previous studies reported the most recent stroke burden when GBD data were updated for 2010, 2013, 2017, and 20192–9. In addition, other studies have detailed the burden of STROKE in different age groups in 20134,5. A study based on GBD 2019 calculated the global estimated annual percentage changes (EAPCs) in IS burden by performing linear regression of data and reported Pearson’s correlation coefficient between age-standardized rates of IS and social development index (SDI). Although ischemic stroke is highly prevalent in the elderly, ischemic stroke in young adults is emerging as a new dilemma in low- and middle-income countries2. Another GBD2019 study focused on the growing burden of ischemic stroke among young people in low SDI regions such as North Africa, the Middle East, and Southeast Asia and analyzed risk factors for IS in young adults7. Based on WHO, effective stroke prevention strategies include reducing the risk associated with hypertension (high systolic blood pressure), elevated lipids, diabetes (high fasting plasma glucose), smoking, low physical activity, unhealthy diet, and abdominal obesity (high body mass index [BMI])9. Changing potentially modifiable risk factors above measured in GBD can reduce the burden of stroke effectively.
The Global Burden of Disease 2021 study estimated the burden of 371 diseases and injuries and 88 risk factors from 1990 to 2021 in seven super-regions, 21 regions, 204 countries and territories (including 21 countries with subnational locations), and 811 subnational locations1,10. During our submission, the GBD Collaboration published a report on the global burden of disease of total stroke and its risk factors and indicated there were 93.8 million (89.0–99.3) prevalent and 11.9 million (10.7–13.2) incident strokes In 2021, there were substantial increases in DALYs attributable to high BMI, high ambient temperature, high fasting plasma glucose, diet high in sugar-sweetened beverages, low physical activity, high systolic blood pressure, lead exposure, and diet low in omega-6 polyunsaturated fatty acids. However, this report does not analyze the World Bank classification and SDI for specific ischemic stroke, nor does it analyze the countries at the forefront of IS management, nor does it use multiple models to predict future trends11. Currently, there are no studies based on GBD 2021 to comprehensively assess the global, regional, and national burden of ischemic stroke stratified by age, sex and the World Bank Income Group Classification, and no studies to conduct frontier analysis of the burden of IS in countries and regions with different SDI stratification to assess the level of health administration and management, and no studies to predict the incidence, prevalence, deaths, and DALYs of IS in the next 15 years by both BAPC and ARIMA models. Besides, we compared the estimated prevalence, incidence, death rate, and DALYs of IS with those that were predicted based on the SDI. We calculated the global EAPCs, which provided annual change about the temporal trends rather than the total percentage change from 1990 to 2021, and offered more accurate information. In particular, we carefully analyzed the distribution of the top-ranked 12 modifiable potential risk factors in different regions, different genders, and different age groups, which is conducive to the development of targeted measures for specific populations on the basis of rigorous statistical data.
Despite global efforts to reduce the burden of IS, disparities persist across countries and regions. Understanding how the IS burden relates to sociodemographic and economic factors is essential for guiding targeted prevention strategies. In this study, we analyze global, regional, and national trends in the incidence, prevalence, mortality, and DALYs of IS, stratified by sex, age, and sociodemographic development. We find that IS accounts for 69.9 million prevalent cases, 7.8 million incident cases, 3.6 million deaths, and 70.4 million DALYs in 2021. The global DALY rate increases with age in both sexes, but declines after age 90–94 in men, while continuing to rise in women aged ≥95 years. We observe that the age-standardized DALY rate initially rises slightly with SDI up to 0.7 and then declines sharply. High systolic blood pressure, elevated LDL cholesterol, and air pollution emerge as the leading contributors to the IS burden. These findings underscore the urgent need for risk-factor-based prevention strategies tailored to national development levels.
Results
Global level
In 2021, 69.9 million (Supplementary Data 1) prevalent cases of ischemic stroke (IS) were published globally, with an age-standardized point prevalence of 819.5 per 100,000, a decrease of 3.5% compared with 1990 (Fig. 1 and Supplementary Data 1). And 7.8 million (Supplementary Data 1) incident cases of ischemic stroke (IS) were reported globally, concerning an age-standardized point incidence of 92.4 per 100,000, a decrease of 15.8% since 1990. IS added up to 3.6 million (Supplementary Data 1) deaths in 2021, with an age-standardized rate of 44.2, a decrease of 39.6% from 1990. In 2021, the case numbers of DALYs for IS globally was 70.4 million (Supplementary Data 1), with a standardized rate of 837.4 DALYs per 100,000, a 34.9% decrease from 1990.
Fig. 1. Global variation in ischemic stroke prevalence.
Age-standardized point prevalence of ischemic stroke (IS) per 100,000 population in 2021, by country (n = global dataset). Data are generated from the Global Burden of Disease (GBD) results tool (https://ghdx.healthdata.org/gbd-results-tool). ASPR Age-Standardized Prevalence Rate; IS Ischemic Stroke. The source data for Fig. 1 are provided in Supplementary Data 9. Actual sizes: Prevalence values ranged from 200 to over 1800 per 100,000 population across countries.
Regional level (V体育ios版)
Figure S1–S4 show the 2021 age-standardized prevalence, incidence, mortality, and DALYs of ischemic stroke across 21 GBD regions, stratified by sex. In 2021, Southern Sub-Saharan Africa (1122), Western Sub-Saharan Africa (1046), and East Asia (1018) had the highest age-standardized point prevalences for IS (per 100,000), while South Asia (497.7), Andean Latin America (515.1) and Central Latin America (552.6) had the lowest (Fig. S1 and Supplementary Data 1). In 2021, Eastern Europe (142.6), East Asia (134.8), and Central Asia (132.9) had the highest age-standardized incidences for IS (per 100,000), whereas the lowest rate occurred in Andean Latin America (46.3), Central Latin America (52), and Australasia (52.8) (Fig. S2 and Supplementary Data 1). In 2021, Eastern Europe (91), North Africa and the Middle East (73.7), and Central Asia (71) had the highest age-standardized death rates for IS (per 100,000), however, Australasia (14.1), High-income Asia Pacific (15.8), and Western Europe (16.7) had the lowest (Fig. S3 and Supplementary Data 1). In 2021, Eastern Europe (1601.2), Central Asia (1356.1), and North Africa and the Middle East (1329.4) had the highest age-standardized DALY rates for IS (per 100,000), but Australasia (249.5), Western Europe (297.7), and Andean Latin America (320.1) had the lowest (Fig. S4 and Supplementary Data 1). Figure S1–S4 demonstrate the age-standardized point prevalence, incidence, death, and DALY rates of IS, respectively, by sex in 2021 for all regions in the Global Burden of Disease study.
Figure S5–S8 show Percentage change in age-standardized prevalence (S5), incidence (S6), death rates (S7), and DALYs (S8) of ischemic stroke (1990–2021) across 21 GBD regions, by sex. The biggest increase in the age-standardized point prevalence of IS, from 1990 to 2021, was found in East Asia (31.5%), which is the only region where ASPR has grown. The biggest decreases in the ASPR of IS were discovered in Tropical Latin America (−28.7%), Southern Latin America (−25.5%), and High-income Asia Pacific (−24.7%) (Fig. S5 and Supplementary Data 1). The biggest increase in the age-standardized incidence of IS, from 1990 to 2021, was found in East Asia (33%). There was no significant change in terms of the ASIR of Southeast Asia. The biggest decreases in the ASIR of IS were discovered in High-income Asia Pacific (−46.6%), Western Europe (−45.1%), and Tropical Latin America (−44.3%) (Fig. S6 and Supplementary Data 1). During the same period, all regions apart from Southern Sub-Saharan Africa (27.5%) showed a decrease in the age-standardized death rates from IS, with the largest decreases in High-income Asia Pacific (−74.9%), Western Europe (−73.4%), and Australasia (−69.2%) (Fig. S7 and Supplementary Data 1). The age-standardized DALY rates decreased in all regions in addition to Southern Sub-Saharan Africa (17.1%) from 1990 to 2021, with the largest decreases in Western Europe (−69.1%), High-income Asia Pacific (−68%), Australasia (−65.1%), and Tropical Latin America (−62%) (Fig. S8 and Supplementary Data 1). Figure S5–S8 demonstrate the percentage change, from 1990 to 2021, in age-standardized point prevalence, incidence, death, and DALY rates for IS by sex, respectively.
The number of prevalent cases of IS increased from 34.7 million in 1990 to 69.9 million in 2021. East Asia, Western Europe, and South Asia had the largest numbers of prevalent cases in 1990, whereas East Asia, South Asia, and Southeast Asia had the largest cases in 2021(Supplementary Data 1). The number of incident cases of IS increased from 4.2 million in 1990 to 7.8 million in 2021. East Asia, Western Europe, and South Asia had the largest number of incident cases in 1990, whereas East Asia, South Asia, and Southeast Asia had the largest cases in 2021(Supplementary Data 1). The number of death cases due to IS increased from 2.3 million in 1990 to 3.6 million in 2021. East Asia, Eastern Europe, and Western Europe had the largest numbers of death cases in 1990, whereas East Asia, South Asia and Southeast Asia had the largest cases in 2021 (Supplementary Data 1). The number of DALYs caused by IS increased from 3.6 million in 1990 to 5.5 million in 2021. East Asia, Eastern Europe, and Western Europe had the largest numbers of DALYs in 1990, whereas East Asia, South Asia, and Southeast Asia had the largest cases in 2021 (Supplementary Data 1).
National level
Figure S9–S11 present the 2021 age-standardized incidence (S9), mortality (S10), and DALYs (S11) of ischemic stroke per 100,000 population across countries. In 2021, the national ASPR of IS ranged from 312.3 to 1603.9 cases per 100,000. In 2021, Ghana (1603.9), Sao Tome and Principe (1422.2), Nauru (1369.0), Madagascar (1365.6), and Botswana (1339.1) had the highest ASPR for IS (per 100,000), whereas Cyprus (312.3), Malta (383.7), Ireland (392.9), Luxembourg (408.8), Portugal (411.6) had the lowest (Fig. 1 and Supplementary Data 3). In 2021, the national ASIR of IS ranged from 38.9 to 214.4 cases per 100,000. In 2021, North Macedonia (214.4), Bulgaria (168.9), Botswana (163.1), Kazakhstan (154.8), Serbia (153.3) had the highest ASIR for IS (per 100,000), whereas Malta (38.9), Puerto Rico (39.2), Ireland (39.6), Luxembourg (41.1), Cyprus (41.8) had the lowest (Fig. S9 and Supplementary Data 4). The national age-standardized death rates for IS in 2021 varied from 7.0 to 216.9 deaths per 100,000. The highest rates were seen in North Macedonia (216.9), Bulgaria (147.6), and Egypt (139.8), whereas the lowest rates were found in Singapore (7.0), Puerto Rico (9.3), and Israel (10.8) (Fig. S10 and Supplementary Data 5). In 2021, the national age-standardized DALY rate of IS ranged from 180.9 to 3037.4 patients per 100,000. The highest rates were seen in North Macedonia (3037.4), Egypt (2462.6), and Bulgaria (2383.6), whereas the lowest rates were in Puerto Rico (180.9), Switzerland (202.3), and Singapore (205.8) (Fig. 11 and Supplementary Data 6).
The percentage change in the ASPR, from 1990 to 2021, differed obviously between countries, with China (34.2%), Turkmenistan (22.4%), Egypt (21.6%), and Lesotho (20.4%) having the largest increases. On the contrary, Portugal (−58.3%), Singapore (−51.6%), and the Republic of Korea (−49.6%) had the largest decreases (Supplementary Data 3). In the same period, Lesotho (40.6%), China (35.7%), and the Philippines (26.8%) had the largest increases in the ASIR. Inversely, the largest decreases were seen in Portugal (−70.3%), Singapore (−65%), and the Republic of Korea (−63.9%) (Supplementary Data 4). Over the same period, Montenegro (65%), Lesotho (55.8%), and Indonesia (36.8%) had the largest increases in the age-standardized death rate, whereas the largest decreases were found in Singapore (−87.6%), Luxembourg (−83.2%), and Portugal (−83%) (Supplementary Data 5). Lesotho (58.9%), Montenegro (40.4%), and Zimbabwe (39.7%) had the largest increases in age-standardized DALY rate of IS from 1990 to 2021. Constantly, the largest decreases during the research period were found in Portugal (−82.7%), Singapore (−81.9%), and Luxembourg (−81.4%) (Supplementary Data 6).
"VSports app下载" Age and sex patterns
Figure. S12–S22 detail the 2021 global ischemic stroke burden by age and sex, covering prevalence (S12–S13), incidence (S14–S16), mortality (S17–S19), and DALYs (S20–S22), including rates, counts, and uncertainty intervals. In 2021, the global prevalence rate of IS in men increased up to 75–79 years and then decreased with advancing age up to 90–94 years and increased again. The global point prevalence of IS in females increased with age and peaked in the oldest age group (≥95 years old). Before the age of 45–49, the prevalence was higher in women than in men, and after that age, the prevalence was higher in men than in women. The number of prevalent cases in males was highest in the 65–69 age group and then decreased with increasing age. However, the number of prevalent cases in females was highest in the 70–74 age group and then decreased with increasing age (Fig. 2, Fig. S12, Fig. S13, and Supplementary Data 2). In 2021, the global incidence of IS in both males and females increased with age and peaked in the oldest age group (≥95 years old). The number of incident cases in males was highest in the 70–74 age group and then decreased with increasing age. The number of incident cases in females was highest in the 70–74 age group. There are more incident cases in women than men in the age group of less than 34 years, more incident cases in men than women in the age group of 40–79 years, and again more incident cases in women than men in the age group of 80 years (Fig. S14, Fig. S15, and Fig. S16). In 2021, the global IS death rate in men increased up to 90–94 years and then decreased with advancing age. However, the global death rate of IS in females increased with age and peaked in the oldest age group (≥95 years old). In the 55–94 age group, the death rate is higher for males than for females. The number of deaths was highest in the 80–84 age groups, for both sexes, after which the numbers decreased with increasing age. In the age group over 80, the number of deaths is higher among women, and in the age group between 30 and 80, the number of deaths is higher among men (Fig. S17, Fig. S18, and Fig. S19). In men, the global DALY rate of IS increased up to age 90–94 years and then decreased with advancing age, whereas, for women, the DALY rate increased up to the oldest age group (≥95 years). This rate was higher in men between 45 and 94 years old. Also, the number of DALYs peaked in the 70–74 age groups in males but peaked in the 80–84 age groups in females (Fig. S20, Fig. S21, and Fig. S22).
Fig. 2. Age and sex distribution of ischemic stroke cases.
Number of prevalent cases globally and prevalence of ischemic stroke (IS) per 100,000 population by age and sex in 2021 (n = global dataset). Lines indicate prevalent cases with 95% uncertainty intervals for men and women. Data are generated from the GBD results tool (https://ghdx.healthdata.org/gbd-results-tool). IS Ischemic Stroke. The source data for Fig. 2 are provided in Supplementary Data 10. Actual sizes: The number of prevalent cases peaked at around 1.8 million in men and 2.0 million in women aged 70–74 years. Prevalence rates ranged from <100 to over 2500 per 100,000 across age groups.
Association with the sociodemographic index
Figure S23–S27 analyze ischemic stroke DALYs, comparing observed vs. expected burden by SDI (S23) and attributing DALYs percentages to top 12 risk factors (e.g., hypertension, diet) across GBD regions (S24–S25) and age groups (S26–S27). At the regional level, we found the association between the sociodemographic index and the age-standardized DALY rate of IS started relatively flat, with a small peak up to a sociodemographic index of about 0.7, and then declined rapidly, from 1990 to 2021. Eastern Europe, Central Europe, North Africa, and Middle East, and Western Sub-Saharan Africa had higher than expected DALY rates, based on their sociodemographic index, from 1990 to 2021. In contrast, Eastern Sub-Saharan Africa, South Asia, and Oceania, central Latin America, Andean Latin America, Caribbean, southern Latin America, High-income North America, Western Europe, and Australasia had lower-than-expected burdens from 1990 to 2021 (Fig. S23).
At the country level, in 2021, the burden of IS rose gently with increasing socioeconomic development until the sociodemographic index reached about 0.35, then slowly declined until the sociodemographic index reached about 0.68, then it reached a small peak again up to a sociodemographic index of about 0.75, but then decreased. Countries and territories such as North Macedonia, China, Bulgaria, Serbia, Latvia, Egypt, and Yemen had much higher than expected burdens, whereas Singapore, Spain, the United States, Ethiopia, and South Sudan had much lower than expected burdens (Fig. 3 and Supplementary Data 3).
Fig. 3. Burden of ischemic stroke by country development level.
Age-standardized disability-adjusted life years (DALYs) rates of ischemic stroke (IS) for 204 countries and territories by Socio-demographic Index (SDI) in 2021. Expected values based on SDI and disease rates in all locations are shown as the black line. Each point represents the observed age-standardized DALYs rate for each country (n = 204). Data are generated from the GBD results tool (https://ghdx.healthdata.org/gbd-results-tool). DALYs Disability-Adjusted Life Years, SDI Socio-Demographic Index, ASR Age-Standardized Rate, IS Ischemic Stroke. The source data for Fig. 3 are provided in Supplementary Data 3. Actual sizes: Observed DALY rates ranged from approximately 200 to over 1400 per 100,000 population.
In terms of the number of prevalent cases in 2021, the five regions stratified by SDI level ranked from highest to lowest were Middle SDI (22,230,670.7), High-middle SDI (17,110,640.3), High SDI (15,864,865.5), Low-middle SDI (10,234,283.1), and Low SDI (4,447,699.2) region (Supplementary Data 1). In terms of ASPR in 2021, the regions ranked from highest to lowest in sequence were High-middle SDI (893.3 per 100,000 population), Middle SDI (838.4), High SDI (813.9), Low SDI (755.7), and Low-middle SDI (669.3) region (Supplementary Data 1). In terms of the percentage change in ASPR from 1990 to 2021, the region with the largest decline in ASPR was the High SDI (−12.8%) region (Supplementary Data 1). The only region where ASPR has increased was the Middle SDI (9.5%) region (Supplementary Data 1).
In terms of the number of incident cases in 2021, the five regions stratified by SDI level ranked from highest to lowest were Middle SDI (2,648,524.6), High-middle SDI (2,243,339.9), High SDI (1,351,912.5), Low-middle SDI (1,120,427.2), and Low SDI region (433,298.4) (Supplementary Data 1). In terms of ASIR in 2021, the regions ranked from highest to lowest in sequence were High-middle SDI (116 per 100,000 population), Middle SDI (103), Low SDI (82.2), Low-middle SDI (80.7), and High SDI (66.1) region (Supplementary Data 1). In terms of the percentage change in ASIR from 1990 to 2021, he region with the largest decline in ASPR was the High SDI region (−37.4%). The only region where ASIR has increased was the Middle SDI region (6.2%) (Supplementary Data 1).
In terms of the number of death cases in 2021, the five regions stratified by SDI level ranked from highest to lowest were Middle SDI (1171548.3), High-middle SDI (1,151,654.6), Low-middle SDI (581,649.1), High SDI (507,950.1), and Low SDI (174,655.2) region (Supplementary Data 1). In terms of ASDR in 2021, the regions ranked from highest to lowest in sequence were High-middle SDI (59.7 per 100,000 population), Middle SDI (51.6), Low-middle SDI (50.9), Low SDI (49.4), High SDI (19.4) region (Supplementary Data 1). In terms of the percentage change in ASDR from 1990 to 2021, the regions in order of decline ranked from highest to lowest were High SDI (−63.9%), High-middle SDI (−46.7%), Middle SDI (−22.4%), Low-middle SDI (−13.7%), and Low SDI (−13.5%) region (Supplementary Data 1).
In terms of the number of age-standardized DALYs in 2021, the five regions stratified by SDI level ranked from highest to lowest were Middle SDI (23,896,856.7), High-middle SDI (21,054,343.3), Low-middle SDI (12,300,861.9), High SDI (8,975,176.2), and Low SDI (4,059,454.6) region (Supplementary Data 1). In terms of age-standardized DALY rate in 2021, the regions ranked from highest to lowest in sequence were High-middle SDI (1076.5 per 100,000 population), Middle SDI (960.7), Low-middle SDI region (942.3), Low SDI (914.3), and High SDI region (395.6) (Supplementary Data 1). In terms of the percentage change in age-standardized DALY rate from 1990 to 2021, he regions in order of decline ranked from highest to lowest were High SDI(−56.8%), High-middle SDI(−42.9%), Middle SDI(−21.4%), Low SDI(−14.9%), and Low-middle SDI(−13.9%) region(Supplementary Data 1).
"VSports注册入口" Association with the standard World Bank classification of economies
In 2021, the lowest age-standardized DALYs were observed in high-income countries (385.13 per 100,000 population, [95% UI, 343.71 to 422.68]) and the highest in low-income countries(1053.94 per 100,000 population, [95% UI, 902.08 to 1254.22]). Similarly, the lowest ASDR was found in high-income countries (19.81 [95% UI, 16.78 to 21.39]), and the high ASDR was found in low-income countries(55.1 [95% UI, 46.79 to 66.7]) and lower-middle-income countries(56.46 [95% UI, 50.69 to 61.91]) and upper-middle-income countries(56.39 [95% UI, 49.02 to 62.9]). The lowest ASIR were found in high-income countries (63.13 [95% UI, 56.04 to 70.56]), and the high ASIR were found in in low- income countries(104.96 [95% UI, 91.98 to 118.07]) and lower-middle-income countries(84.06 [95% UI, 72.86 to 95.63]) and upper-middle-income countries(118.35 [95% UI, 99.56 to 137.76]). The lowest ASPR was found in lower-middle-income countries (694.04 [95% UI, 635.91 to 750.41]), and the highest ASPR was found in low-income countries(936.37 [95% UI, 888.99 to 980.65]).
To summarize, while more economically developed countries had the lowest burden of IS(measured in age-standardized DALYs, ASDR, and ASIR). (Supplementary Data 2).
"V体育官网" Risk factors
The proportion of DALYs on account of IS attributable to individual risk factors differed across the Global Burden of Disease regions. The proportion of DALYs on account of IS attributable to individual risk factors by region and sex is shown in Fig. 4, Fig. S24, and Fig. S25. The proportion of DALYs due to IS that were attributable to dietary risks, tobacco, alcohol use, and other environmental risks was higher in men. Inversely, high body mass index, kidney dysfunction, and low physical activity were higher in women (Fig. 4 and Supplementary Data 4). Globally, high systolic blood pressure (58.0%), high LDL cholesterol (29.4%), air pollution (25.8%), dietary risks (18.3%), high fasting plasma glucose (17.6%), and tobacco (15.1%) had the highest contributions to DALYs on account of IS (Fig. S24 and Fig. S25). Among the five regions divided according to SDI, the proportion of air pollution in low SDI (47.4%) and low-middle SDI (38%) countries is relatively high, indicating that air pollution is a particular concern. In countries with high SDI, the proportion of air pollution was only about 11.1%. High-income North American countries had the lowest proportion of air pollution among all regions, at only 3.1%. However, the proportion of high fasting plasma glucose in high-income North American countries was higher than in other regions. The proportion of alcohol use in Western Europe and Australasia was higher than in other regions. The proportion of high body-mass index was higher in high SDI countries High-income North America as well as North Africa and the Middle East. In the 25–44 age group, hyperlipidemia is the most important risk factor (Fig. S26). For people over 45 years of age, high blood pressure is the most important risk factor for IS (Fig. S26). The influence of dietary factors on IS decreases gradually with the increase in age (Fig. S26). The proportion of air pollution for young people is higher than that for old people (Fig. S26). The proportion of tobacco use in patients aged 30–60 years is of great significance (Fig. S26). The proportion of High fasting plasma glucose among people aged 75–79 was higher than that of other age groups (Fig. S26). The proportion of High body mass index among people aged 35–39 was higher than that of other age groups (Fig. S27). The proportion of low physical activity among people aged 35–39 was higher than that of other age groups (Fig. S27). The proportion of other environmental risks among people aged 65–69 was higher than that of other age groups (Fig. S27). An interesting observation can be made that alcohol has a protective effect on the development of IS in people aged 15–19 years (Fig. S27). We speculate that this may be due to the protective effect of moderate alcohol consumption against IS and that confounding factors such as other social characteristics of adolescents who drink alcohol in this age group, such as being socially active, enjoying sports, and having discretionary money, may also be responsible. The proportion of alcohol use among people aged 50–59 was higher than that of other age groups (7.2%). The proportions of nonoptimal temperature were higher in the two extreme age groups of 95 years (7.2%) and older and younger than 5 years (4.8%). Nonoptimal temperature is a critical risk factor for adolescents under the age of 20 (Fig. S27). Kidney dysfunction is an important risk factor for the age group of 95 years (12.4%) and older (Fig. S27). Because these risk factors coexist with each other, the PAF does not add up to.
Fig. 4. Key risk factors contributing to ischemic stroke burden.
Percentage of disability-adjusted life years (DALYs) due to ischemic stroke (IS) attributable to each risk factor by sex for the 21 GBD regions in 2021 (n = 21 regions). Data are generated from the GBD results tool (https://ghdx.healthdata.org/gbd-results-tool). DALYs = Disability-Adjusted Life Years; LDL = Low-Density Lipoprotein; IS = Ischemic Stroke. The source data for Fig. 4 are provided in Supplementary Data 12. Actual sizes: The most significant contributors were high systolic blood pressure (up to 60%), high LDL cholesterol (up to 40%), and ambient particulate matter pollution (up to 30%).
The estimated annual percentage change (EAPC) of IS
From 1990 to 2021, the EAPCs of global level in the ASPR, ASIR, ASDR, and ASR of DALY were −0.18(95% CI: −0.21, −0.16), −0.67(95% CI: −0.76, −0.58), −1.83 (95% CI: −1.92, −1.74) and −1.59 (95% CI: −1.68, −1.5), respectively, which presented a decrease in the GBD 2021 on account of IS (Supplementary Data 7). The EAPC of ASPR, in East Asia, the only region where EAPC increased, was 0.95 (95% CI: 0.89, 1). The largest decline in the EAPC of ASPR was in Tropical Latin America, which was −1.24 (95% CI: −1.3, −1.18). The EAPC of ASPR, in the Middle SDI region, was 0.27 (95% CI: 0.24, 0.3), which has increased. The EAPC of ASIR, in East Asia, the only region where EAPC increased, was 0.86 (95% CI: 0.8, 0.92). The largest decline in the EAPC of ASIR was in Western Europe, which was −2.12 (95% CI: −2.21, −2.03). The EAPC of ASIR, in the Middle SDI region, was 0.12 (95% CI: 0.07, 0.16), which has increased. However, the EAPC of ASIR, in High-income Asia Pacific, was −2.53 (95% CI: −2.73, −2.33), which has decreased maximally. Except for Southern Sub-Saharan Africa, whose EAPC was 0.94 (95% CI: 0.47,1.42), the EAPCs of ASDR in different regions have all decreased. In the high-income Asia Pacific and High SDI region, the EAPCs of ASDR have deceased maximally, were −4.76(95% CI: −4.91, −4.6) and −3.58(95% CI: −3.71, −3.44) respectively. Except for Southern Sub-Saharan Africa, whose EAPC was 0.64 (95% CI: 0.22, 1.06), the EAPCs of age-standardized DLAY rates in different regions have all decreased. In high-income Asia Pacific and High SDI regions, the EAPCs of age-standardized DLAY rate have deceased maximally, were −3.99 (95% CI: −4.14, −3.83) and −2.98 (95% CI: −3.11, −2.85), respectively. More detailed information is in Supplementary Data 7.
Frontier analysis of IS burden
Figure S28–S36 project future ischemic stroke burden, including SDI-DALYs trends (S28) and 2036 age-standardized prevalence, incidence, mortality, and DALYs cases by SDI level for males (S29–S32) and females (S33–S36). To estimate the effective difference between each country and region and the border, the 2021 DALYs and SDI were put to use (Fig. 5, Fig. S28, Supplementary Data 8 and Supplementary Data 5). The top five countries or regions with the largest effective difference from their frontier included North Macedonia, Egypt, Bulgaria, Iraq, and Serbia.
Fig. 5. Health system performance in managing ischemic stroke burden.
Frontier analysis based on Socio-demographic Index (SDI) and ischemic stroke (IS) DALYs rate in 2021 (n = global dataset). Data are generated from the GBD results tool (https://ghdx.healthdata.org/gbd-results-tool). DALYs Disability-Adjusted Life Years, SDI Socio-Demographic Index, IS Ischemic Stroke. The source data for Fig. 5 are provided in Supplementary Data 13. Actual sizes: Effective difference values ranged from –500 to +600 DALYs per 100,000 population across countries.
Given the position in the development spectrum, the top five countries or regions with the lowest DALY rates had the lowest effective differences, including Somalia, Puerto Rico, Ethiopia, El Salvador, and Israel (Supplementary Data 8).
The solid black line represents the frontier, and the dots represent the countries and regions. The blue dots indicate the upward trend, while the red dots indicate the opposite.
Among countries with different SDI levels, countries that have played a leading role in the prevention and control of IS include Germany, Monaco, Lithuania, the Republic of Korea, Taiwan (Province of China), Nepal, Uganda, South Sudan, Ethiopia, and Somalia. These countries at the forefront of prevention and control management are role models for the world to follow.
Prediction analysis of IS burden (V体育官网入口)
The prevalence rate, incidence rate, death rate, and DALYs rate will change variously along with time and in different regions. To precisely determine the true epidemiology of IS in different countries worldwide, it is indispensable for us to conduct higher-quality epidemiological research. According to the BAPC model, the future prevalence of IS in the world will increase and will be expected to reach 912.4 per 100,000 population for males, and 873.5 per 100,000 population for females, respectively. The future incidence of IS in the world will increase and will be expected to reach 109.3 per 100,000 population for males and 91.4 per 100,000 population for females in 2036. The future death rate of IS in the world will decease and will be expected to reach 43.6 per 100,000 population for males, and 31 per 100,000 population for females, in 2036. The future DALYs rate of IS in the world will decrease and will be expected to reach 881.4 per 100,000 population for males, and 665.8 per 100,000 population for females, respectively, in 2036(Fig. S29–S36). The ARIMA model was used to predict the same outcomes (incidence, prevalence, mortality, and DALYs) from 2021 to 2036, and the results were compared to the projections from the BAPC model. Both models produced consistent trends, suggesting robustness in the long-term predictions. (Fig. 6 and Supplementary Data 6)
Fig. 6. Projected trends in ischemic stroke burden by sex.
Predicted trends for age-standardized incidence (a and b), prevalence (c and d), death rate (e and f), and DALYs (g and h) of ischemic stroke (IS) for males and females, based on the Autoregressive Integrated Moving Average (ARIMA) model (n = time series dataset). The shaded areas represent 2.5–97.5% uncertainty intervals of the predictions, with darker shading indicating central quantiles and lighter shading representing wider intervals. Data are generated from the GBD results tool (https://ghdx.healthdata.org/gbd-results-tool). ASPR Age-Standardized Prevalence Rate, DALYs Disability-Adjusted Life Years, IS Ischemic Stroke, ARIMA Autoregressive Integrated Moving Average. The source data for Fig. 6 are provided in Supplementary Data 14. Actual sizes: By 2036, projected incidence rates range from 200 to 350 per 100,000, prevalence from 1000 to 1500, death rates from 50 to 120, and DALY rates from 500 to 1000, depending on sex and region.
Discussion
"VSports" Principal findings
In this research, based on data from the Global Burden of Disease 2021 study, we have provided up-to-date information on the prevalence, incidence, death, and DALY cases of IS from 1990 to 2021, together with the age-standardized rates across 204 countries and territories. Globally, IS accounted for 69.9 million prevalent cases, 7.8 million incident cases, 3.6 million deaths, and 70.4 million DALYs in 2021. Although the age-standardized point prevalence, deaths, and DALY rates due to IS have decreased over the past three decades, the absolute counts are increasing, which could be a result of population growth, as well as population aging and a rise in life expectancy.
Comparison with other studies
A study based on GBD 2010 reported there were about 11,569,000 incident IS cases (63% in lower-middle-income countries [LMIC]), about 2,835,000 deaths from IS (57% in LMIC), and approximately 39,389,000 DALY lost due to IS (64% in LMIC)3. From 1990 to 2010, there was an increase globally in terms of absolute number of people with incident IS cases (37% increase), deaths from IS (21% increase), and DALY lost due to IS (18% increase)3. Age-standardized IS incidence, DALY lost, mortality, and mortality-to-incidence ratios in high-income countries declined by about 13%, 34%, 37%, and 21%3. In LMIC there was a modest 6% increase in the ASIR of IS despite modest reductions in mortality rates, DALY lost, and mortality-to-incidence. The study focuses on a single modifiable risk factor which is Tobacco consumption and pointed in both 1990 and 2010, the top-ranked countries for IS deaths that could be attributed to tobacco consumption were China, Russia, and India3. In the first decade of the 21st century, the highest incidence rates of IS were found in Eastern Europe, Central Asia, East Asia, and North Africa/Middle East3. However, in our study, Eastern Europe, East Asia, and Central Asia had the highest ASIR for IS. The increasing incidence of IS in East Asia is related to the improvement of economic level and diet structure in East Asian countries in the past decade. In this study, we did not use the World Bank country income level classification but adopted the SDI classification. The Socio-demographic Index (SDI) is an indicator that comprehensively reflects the development level of a country or region. It is calculated by the World Bank based on indicators such as GNI per capita, average years of schooling, and total fertility rate. SDI values range from 0 to 1, with higher values representing higher levels of development. The World Bank generally classifies countries into five tiers based on SDI values: low SDI, low-middle SDI, middle SDI, high-middle SDI, and high SDI. The World Bank’s income level classification is based on GNI per capita, which divides countries into four income groups: low income, lower middle income, upper middle income, and high income3. SDI assesses a country’s level of social development from a more integrated perspective. The Global Burden of Disease Stroke Expert Group reported the methodology of the Global and Regional Burden of Stroke Study in 2012, which ensured that global health policy decisions are based on the most up-to-date, valid, and reliable epidemiological information available. It provides a framework for standardized assessment of the burden of stroke12.
A study based on GBD 2019 analyzed temporal trends of prevalence for stroke, including ischemic stroke (IS), intracerebral hemorrhage (ICH), and subarachnoid hemorrhage (SAH) at the global, regional, and national levels. Joinpoint regression analysis was adopted, and each delineated segment’s epidemiological course underwent additional scrutiny via the computation of the Annual Percentage Change (APC) and its associated 95% confidence interval (CI). Besides, the average APC (AAPC) was calculated across all segments with weightings applied by the width of each specific interval. In 2019, the global ASPR of IS was 950.973 per 100,000 population (95% UI: 849.825 to 1064.059). Between 1990 and 2019, there was a statistically significant decline represented by a low AAPC of −0.059% (95% CI: −0.077 to −0.043), especially from 1990 to 1994. In 2019, the Eastern Mediterranean region demonstrated the highest ASPR, while the South-East Asia region reported the lowest ASPR8. However, in our research, Southern Sub-Saharan Africa, Western Sub-Saharan Africa, and East Asia had the highest ASPR for IS, while South Asia, Andean Latin America, and Central Latin America had the lowest in 2021. Changes in ASPR in the Eastern Mediterranean region may indicate that health policymakers have adopted policies based on GBD research and achieved good results, and other regions should actively learn from their experience. This change may be due to the widespread adoption of the Mediterranean diet. In 2019, the United Arab Emirates recorded the highest ASPR, while Nepal reported the lowest ASPR. China exhibited the highest AAPC, while Singapore recorded the lowest AAPC8. In 2021, Ghana had the highest ASPR for IS, whereas Cyprus had the lowest. So, changes in IS country regions highlight the impact of GBD research on the global NCD epidemiological landscape. From 1990 to 2021, the global decline in ASPR, ASIR, and ASDR is due to improvements in primary and secondary prevention strategies for IS and regulatory control of major risk factors for IS, as well as improvements in acute management techniques and logistics, such as prehospital transport treatment for IS pathology. Improved management of chronic diseases such as hypertension and diabetes, complex acute care therapy including thrombolysis and intervention, and organized stroke care units have also contributed to a significant decline in ASPR. Considering regions with a focused approach to primary prevention and public health initiatives, such as Europe and North America, have seen pronounced decreases in IS prevalence, variations in access to healthcare, and the adoption of prevention strategies contribute to the regional disparities observed13–19.
Another study about global, regional, and national temporal trends of diet-related ischemic stroke mortality and disability from 1990 to 2019 evaluated six specific dietary factors, including sodium, red meat, fiber, vegetables, whole grains, and fruits, to determine their individual and joint impact on ischemic stroke. They found high sodium diet was still a key driver of diet-related ischemic stroke. Besides, they found the developing countries with weak social and economic foundations were in the face of bigger challenges due to the ongoing burden of diet-related strokes compared with developed countries. In our study, the percentage of dietary risk in different SDI regions ranked from High to Low as High−middle SDI, Middle SDI, Low SDI, High SDI, and Low−middle SDI. This may be due to the fact that high-income countries pay more attention to healthy eating after food freedom, while developing countries are still in the stage of upgrading the level and quantity of diet, and do not pay attention to the quality and health impact of diet20.
Previous studies have found that from 1990 to 2019, the ASPR trend of IS shows a significant decrease in women and an increase in men. This is consistent with our study showing that men have a heavier burden of IS than women. Our results show that diet, tobacco, alcohol abuse, and other environmental risk factors are significantly elevated risk factors for men compared to women, while physical inactivity and high BMI are significantly higher risk factors for women than men21. Previous studies have suggested that the prevalence of unhealthy diet and physical inactivity among men may contribute to the sex difference, but the analysis actually calculated that men should limit alcohol intake and reduce tobacco use may reduce the incidence of IS in men22. Of course, the difference between our findings and those of previous studies may be related to the fact that men’s work has stopped and they have more time for physical exercise under the influence of COVID-19, and men’s fitness awareness has increased. Women should also raise their awareness of fitness and prevent diseases through exercise. Health policymakers should pay attention to gender disparities and take targeted measures to improve them. The study found that countries with ASPR of IS vary widely, with a higher overall trend of ASPR in high-middle SDI countries compared to countries with High SDI, which may be associated with a higher global prevalence of hypertension in developing countries. By strengthening community screening, improving lifestyle, strengthening health education and lifestyle counseling, and improving drug access and free clinics in poor areas, the global IS prevalence difference can be reduced. The increase in the number of IS prevalent cases may be due to the improvement of acute care and medical level has reduced the death of patients after stroke, the aging of the population and the extension of average life expectancy, and the improvement of nursing level has extended the life span of stroke patients22.
Strengths and limitations
In contrast to previous studies that only analyzed changes in stroke prevalence according to GBD 2019, we comprehensively evaluated the entire spectrum of population-level ischemic stroke dynamics, including incidence, prevalence, mortality, and DALYs. At the same time, we focus on a pathological subtype of stroke, ischemic stroke, to further explore the epidemiological trend of IS and its risk factors, and make future predictions. Because of the large heterogeneity between diseases, digging deeper into a disease is conducive to precise treatment and developing preventive strategies.
For areas with sparse data, we use data from data-rich areas to simulate and estimate, but the calculation model ultimately has an inherent error range, which cannot fully reflect the actual disease burden. However, this limitation is an unavoidable limitation for research based on the GBD database, which requires further refinement and improvement of the GBD database, as well as strengthening the recording and management of medical data in areas with scarce data. On the other hand, another study based on GBD2019 assessed the overall burden of all kinds of stroke and the population attributable fraction (PAF) of DALYs associated with 19 risk factors by sex, age group, and World Bank country income level9. We focused on ischemic stroke, the most common disease in stroke. In order to avoid excessive stratification of risk factors resulting in too small a proportion of each factor and too coarse stratification to accurately measure risk factors, we selected 12 leading risk factors (Level 3), and calculated population attributable fractions (PAFs) of DALYs by age, region and gender. Compared with the GBD2019 study on risk factors, we have adopted different data visualization methods for the study of risk factors, but our study has comprehensively covered different regions, ages, and genders. We also categorize risk factors, such as metabolic factors, behavioral factors, and environmental factors. We can also visualize the age-standardized percentage of IS DALYs attributable to all risk factors in males and female, the number of DALYs attributable to all risk factors combined, all ages, both sexes, and Global ischaemic stroke-related DALYs attributable to risk factors in 1990 and 2021, and so on. In addition, our research can be refined into the distribution of each risk factor in different countries and displayed on a world map.
A study based on GBD 2019 reported that the ASIR and ASDR of IS and ASR of DALYs due to IS decreased from 1990 to 2019 in high SDI regions. The ASIR of IS remained stable from 1990 to 2015 in middle SDIs, and then continuously increased from 2015 to 2019. However, the ASIR and ASDR of IS and ASR of DALYs due to IS had steadily and markedly decreased in high SDI and high-middle SDI regions since 1995, whereas the burden of ischemic stroke remained unchanged in low-middle and low SDI regions from 1990 to 201923. In our study, the EAPC of prevalence and Incidence in Middle SDI region were 0.27 and 0.12 from 1990 to 20212. The findings suggest that moderate SDI countries face rising morbidity and prevalence after 2015, and reflect the impact of new socio-economic development modalities on health and general health. The survival rate of ischemic stroke patients in low and middle-income countries is worse than that of patients in high-income countries, which may lead to an underestimation of the burden of ischemic stroke in low and middle-income countries.
Studies have shown that in areas with higher SDI, the proportion of IS in the elderly is higher and the proportion in the young is lower, which is related to population aging and low fertility24.
In 2019, the worldwide ASIR of IS in females was slightly higher than that in males, while the ASDR of IS and the ASR of DALYs due to IS in females were lower than those in males. The higher risk in women among older patients may be related to women’s higher life expectancy25. Previous studies have estimated that at least half of all strokes could be prevented through changes to lifestyle factors. The government should reduce the abuse of tobacco and alcohol through legislation and taxes on tobacco and alcohol, improve health care conditions, combat air pollution, and improve inequalities in health care, education, and employment2. The strength of our study is the use of the latest data from the GBD2021 up-to-date database and the revision of the original burden of disease estimates based on new data and improved methodologies. The quality and accuracy of GBD data in some underdeveloped areas cannot be guaranteed when estimating etiological-specific mortality and nonfatal burden. Research organizations and social groups should increase capital and manpower input to build a complete disease registration system and death information system in underdeveloped areas.
In 2019, adult young women had a higher age-standardized incidence of ischemic stroke than men, while age-standardized mortality and DALY rates were lower than men. This can be due to factors such as patent foramen ovale, migraines, preeclampsia, high blood pressure during pregnancy, oral hormonal contraceptives, and more26. In our study, it was also observed that estrogen has a protective effect against IS in people aged 40 to 50 years, and the incidence of IS in women younger than 40 years is higher than that in men, which is probably due to the above reasons.
It is essential for implementing effective individual-level changes and primary and secondary prevention measures to develop guidelines specifically for the best and timely identification and management of stroke in different populations. To the best of our knowledge, this is the first research to estimate the latest epidemiological patterns of and risk factors for ischemic stroke at the global, regional, and national levels by sex, age, and SDI and to conduct the future trend forecast and frontier analysis. Compared with Ding’s research, we also provided the leading risk factors for the disease burden for young adults in different SDI regions, which has important public health significance for the prevention of ischemic stroke in this age group2.
Our study comprehensively listed the distribution of risk factors in different ages, genders, and regions according to the contribution of risk factors, instead of selecting some risk factors according to common sense or experience to study their effects. The results of our risk factor study are conducive for regions and countries to take targeted primary prevention measures on their circumstances. In addition, the distribution of risk factors changes dynamically with the development of the social economy, which is time-sensitive. Therefore, we should objectively and accurately assess the importance of risk factors rather than relying on experience to determine which risk factors are most important. The development of imaging techniques has also improved the detection of IS, which has increased the incidence compared to the past27.
GBD imputable burden estimation has implemented more explicit bias correction and improved risk exposure estimation than previous studies, but the availability and quality of raw data remain its existing limitations. In addition, we need to design rigorous prospective clinical trials to verify the true biological effects and dose-response relationships of various risk factors27.
Compared with developed countries, the decrease in stroke mortality among people aged 0–19 years from 1990 to 2013 was lower in developing countries, especially among newborns aged 0–27 days, which may reflect the higher incidence of undiagnosed stroke in developing countries due to limited imaging resources, lower visit rates, and poor health facilities. With significant increases in life expectancy in low- and middle-income countries, noncommunicable diseases are replacing infectious diseases as the leading causes of disability and death. A 2010 literature review recommended that the GBD include VTE in its measurement for a specific cause of death28. For the construction and improvement of the GBD database, we suggest that the types of ischemic stroke diseases and pathological types of various tumors can be refined in the future, such as the classification of the ischemic stroke into the large atherosclerotic ischemic stroke, cardiogenic embolic stroke, small-vessel occlusive stroke, etc., and the classification of breast cancer into triple-negative breast cancer. Her-2 overexpressed breast cancer, hormone receptor-positive breast cancer, etc., the nervous system tumors were refined into glioma, craniopharyngioma, ependymoma, meningioma, etc. Because there is great heterogeneity in risk factors, prognosis, prevention, and treatment for different pathological types of diseases, the improvement of the database is conducive to accurate prevention and treatment. The common pathology of ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE) is thrombosis. Studies have shown that the occurrence of venous thromboembolism is positively correlated with age28,29. Previous studies have found that age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology. This study explained at a mechanistic level the increase in the incidence of IS observed with age in our study. Clinical trials have shown that estrogen, represented by 17β-estradiol, can reduce brain damage in ischemic stroke by modulating the response of immune cells30. This mechanism explained the conclusion found in our study that the mortality rate and the number of deaths of male IS patients are higher than that of females, and for middle-aged IS patients, the incidence rate and the number of incident cases of female are lower than that of male, which is conducive to guiding global researchers to develop alternative treatment drugs31. A population-based cohort study involving 27,204 individuals ≥60 years old in Southern Catalonia, Spain, which collected all cases of hospitalization from ischemic stroke (confirmed by neuro-imaging) from 01/12/2008 until 30/11/2011, reported that the mean incidence rate reached 453 cases per 100,000 person-years. Besides, Maximum rates appeared among individuals with a history of prior stroke (2926 per 100,000), atrial fibrillation (1815 per 100,000), coronary artery disease (1104 per 100,000), nursing-home residence (1014 per 100,000), and advanced age ≥80 years (1006 per 100,000). Age, history of prior stroke, history of coronary artery disease, atrial fibrillation, diabetes mellitus, and smoking emerged independently associated with an increased risk of ischemic stroke. According to the elderly population, the corresponding stratification factors should be adopted, especially the nursing care of the elderly in the nursing home and the prevention of cerebral infarction32.
In our study, we found that high systolic blood pressure, high LDL cholesterol, and high fasting plasma glucose are the most important risk factors for IS in elderly patients, and the management of comorbidities of chronic senile diseases as well as the early detection and standardized treatment of hypertension, diabetes, and hyperlipidemia are the key to solving the occurrence of cerebral infarction in elderly patients and improving their prognosis.
A study reported the prevalence of an estimated glomerular filtration rate (GFR) determined by the Modification of Diet in Renal Disease equation less than 60 mL/min/1.73 m(2) was investigated in older persons in an academic nursing home with either hypertension, diabetes mellitus, coronary artery disease (CAD), peripheral arterial disease (PAD), ischemic stroke, or congestive heart failure (CHF). The results of the study revealed older persons with hypertension, diabetes mellitus, CAD, PAD, ischemic stroke, or CHF have a high prevalence of moderate or severe renal insufficiency and should be treated optimally to reduce the increased risk of cardiovascular events and mortality in this high-risk population33. This supported our findings that renal dysfunction IS also an important risk factor for IS in the elderly population. This suggested that the occurrence of renal dysfunction and IS may be mutually causal. Improving the outcome of diseases requires the joint efforts of multiple disciplines and the improvement of the comprehensive treatment level of community doctors and nursing home doctors for elderly diseases. Air pollution has a serious impact on stroke DALYS in people of all ages. The intensification of global industrialization and urbanization, the dramatic increase in the number of cars, the destruction and felling of forests and trees, the increase of reinforced concrete buildings, the reduction of green areas, the burning of large amounts of oil and coal, and the imperfect air control have all led to the deterioration of air quality in recent years. Health management departments should strengthen cooperation with environmental protection departments, expand the area of green plants, use environmentally friendly energy, and strengthen the research and development of industrial toxic and harmful gas treatment and waste gas cleaning equipment. People should wear masks that filter air when they go out. The world should work together to reduce the global burden of IS at its source. High body mass index and low physical activity have become an important disease risk factor in young and middle-aged people aged 30–50 years. This age group is at the age of starting a family and becoming the breadwinner of the family. The increasing pressure of social competition, the extension of working hours and work intensity, and the lack of awareness of long-term health management are all reasons for this situation. Managers should strengthen education among young people, enhance the awareness of physical exercise among young and middle-aged people, regularly hold public physical exercise activities with full participation, improve basic physical exercise facilities, and strengthen regular physical examinations of young people.
Dietary risks
For patients aged 20–25 years, dietary risks are the second highest risk factor after high LDL cholesterol. A study reported the association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. The results showed that the largest numbers of estimated diet-related cardiometabolic deaths were related to high sodium (66 9.5%), low nuts/seeds (8.5%), high processed meats (8.2%), low seafood omega-3 fats (7.8%), low vegetables (7.6%), low fruits (7.5%), and high sugar-sweetened beverages (51 694; 7.4%). Between 2002 and 2012, population-adjusted US cardiometabolic deaths per year decreased by 26.5%. The greatest decline was associated with insufficient polyunsaturated fats (−20.8% relative change), nuts/seeds (−18.0%), and excess sugar-sweetened beverages (−14.5%). The greatest increase was associated with unprocessed red meats (+14.4%)34.
primary prevention of first stroke and secondary prevention of recurrent stroke is a high priority. Ischemic stroke prevention is multifaceted, encompassing both primary and secondary strategies to reduce the incidence and recurrence of stroke. Primary prevention strategies include the following steps. First of all, people should change their lifestyle and diet, and adopting a healthy lifestyle and a balanced diet is fundamental in curbing the risk of ischemic stroke. Secondly, people should pay attention to the management of comorbidities and actively treating conditions like hypertension, diabetes mellitus, and dyslipidemia is crucial for stroke prevention. Besides, patients identified as having a high vascular risk may benefit from antiplatelet medications to prevent clot formation. Furthermore, for individuals with atrial fibrillation, anticoagulant therapy is essential to mitigate stroke risk. As far as the secondary prevention strategies are concerned, on one hand, doctors should select symptomatic patients who may undergo carotid endarterectomy or stenting to improve blood flow and prevent recurrent stroke. On the other hand, following a cryptogenic stroke, closure of a patent foramen ovale may be considered to reduce the risk of future strokes. Thirdly, Treating insulin resistance is an important aspect of secondary prevention, particularly for diabetic patients. Comprehensive medical management of intracranial stenosis is vital to prevent stroke recurrence35. Inflammatory disorders, infection, pollution, and cardiac atrial disorders independent of atrial fibrillation, single-gene disorders which may cause rare, hereditary disorders, and common and rare genetic polymorphisms affect the incidence of IS. Strengthening research on stroke risk factors and genetics could help identify those at risk for stroke and develop ways to prevent stroke in those at risk36. The Mediterranean diet (MedDiet), which is abundant in minimally processed plant-based foods, rich in monounsaturated fat from olive oil, but lower in saturated fat, meats, and dairy products, is reported an ideal nutritional model for IS37. Artificially sweetened soft drink consumption had a relationship with a higher risk of IS and dementia. In China, for example, in recent years, sugary milky tea, sugary fruit tea, sugary coffee, sugary cola, and other soft drinks have become popular drinks for young people under the age of 30. Many young people are not aware of the risks of sugary drinks causing IS, so health authorities should strengthen the soft drinks market and raise awareness among young people to reduce their intake of soft drinks38. A study reported that a lower risk of IS was found in people who adhered to a healthful plant-based diet. Reducing the intake of these unhealthy diets and sticking to a Mediterranean or vegetarian diet can help reduce the risk of IS39. Stroke is the fifth-highest cause of death in the US and a leading cause of serious long-term disability with particularly high risk in Black individuals40. One study showed that although the recurrence of ischemic stroke declined in recent years, the reduction was lower in blacks and women. Counties with a higher proportion of black and uninsured individuals, as well as those with less income inequality and preventive care, were more likely to have persistently high rates of recurrent ischemic stroke. Leifheit et al. ‘s data also confirmed previous research that blacks have a higher rate of stroke recurrence than whites41–43. The study suggests that further attention should be paid to treatment and prevention of relapse for women, blacks, and people living in high-risk areas of the Midwest and South.
A study to investigate sex and race differences in the association between fasting blood glucose (FBG) and risk of ischemic stroke (IS) suggested that sex was the major contributor to differences by race/sex subgroups44. A research reported that heart failure which was highly prevalent in acute ischemic stroke and associated with worse outcomes was highly prevalent in stroke patients of Black race, particularly in younger cohorts, and in a manner not fully explained by cardiovascular profiles45. A study was conducted to determine the qualitative and quantitative contributions of conventional risk factors for ischemic stroke and key pathophysiological subtypes in West Africans. The adjusted odds ratio for the 8 dominant risk factors for IS were hypertension, (10.34%); dyslipidemia (5.16%); diabetes (3.44%); low green vegetable consumption (1.89%); red meat consumption (1.89%); cardiac disease (1.88%); monthly income $100 or more (1.72%); and psychosocial stress (1.62%)46. Hypertension, dyslipidemia, and diabetes were confluent factors shared by small-vessel, large-vessel, and cardio-embolic subtypes. Individuals of African descent bear a higher burden of hypertension-related diseases, particularly ischemic stroke (IS), compared to other racial/ethnic groups. The pathophysiological disruption of the renin-angiotensin-aldosterone pathway can improve blood pressure control and prevent stroke in populations of African descent. Cross-continental comparative data from the United States and Ghana show that the prevalence of refractory hypertension among stroke survivors is 42.7% in native Africans, 16.1% in African Americans, and 6.9% in non-Hispanic whites, with a statistically significant difference (p = 2.83e-11). A multicenter clinical trial conducted in three African countries (Nigeria, Kenya, and South Africa) on patients without stroke indicated that, compared to standard treatment, the physiological analysis of plasma renin activity and aldosterone for personalized selection of antihypertensive drugs could achieve better blood pressure control with fewer medications within 12 months. In Ghanaian ischemic stroke survivors without renin-aldosterone analysis data, an analysis revealed that patients with low renin phenotype did not show significant blood pressure reduction after taking 3–4 antihypertensive drugs for 12 months, despite good compliance46,47. A study was conducted to identify potential roles of regulatory miRNA, intergenic noncoding DNA, and intronic noncoding RNA in the biology of ischemic stroke which was the first-ever genome-wide association study (GWAS) of stroke in indigenous Africans47. Finding therapeutic targets at the genetic level is expected to be the direction of research aimed at the high incidence of IS in Africa.
As for the study of 2021, in the process of careful analysis and data verification, writing discussion, etc., we found a study related to IS and GBD that was just retrieved on PubMed about a week before submission. After careful comparison, we found that, however, concerning the reviewer’s comments, there may be several minor errors probably not reflected in the results in the Lancet clinical medicine27. Firstly, the GBD 2021 study covers the burden of 371 diseases and injuries, not 369 diseases. This reference is still based on GBD’s 2019 study, without verifying the latest data for 2021, but directly thinking that there is still the same amount in 2021, which is not rigorous and serious. Secondly, in the introduction section, the study states that stroke is the second leading cause of death worldwide. According to the latest study, stroke has become the third leading cause of death after the COVID-19 pandemic. The study did not rigorously identify the source of the data. Thirdly, in terms of the calculation of risk factors, this study selected four risk factors but did not explain why these four factors were selected and subjectively considered to be important factors, according to our study, these four factors are not ranked in the top. In addition, the proportion of attributable risk factor scores of tobacco in the world is 15.5. Our study shows 15.1, after checking our data, we believe that our data and results are not problematic. During the months since this manuscript was submitted, additional GBD2021 studies addressing stroke and ischemic stroke have appeared. In one research published on the Lancet, the slope index of inequality (SII) and the concentration index were calculated to quantify the absolute and relative cross-country inequalities in the burden of stroke and its subtypes48. Another research added Joinpoint regression analysis and pointed particulate matter pollution and low temperatures were significant environmental and occupational risk factors for ischemic stroke as well as smoking and a diet high in sodium were identified as key behavioral risk factors49. Besides one research reported the burden of IS from 1992 to 2021 within BRICS-plus countries by age-period-cohort modeling50. Our study adds frontier analysis, comprehensive analysis of World Bank income level classification and SDI classification, cross-validation of two prediction models, and tell the story of IS completely and comprehensively.
However, the above discussion is only for the specific content of the study, not for individuals and researchers. All scientific researchers are good friends and should tolerate and help each other to jointly promote the development of world health and benefit human health. We’re just looking at some differences before we make an objective statement. In future studies, we can conduct a comprehensive stroke burden assessment, and we can also more detail the distribution of risk factors at the national level, and even accurate data for each province, which depends on GBD expert collaborators to conduct more detailed data statistics and publication. However, limited by the length and timeliness of the paper, we believe that the existing work content has been able to assess the burden of IS in a more comprehensive and objective way, and we will make this study more detailed in the future.
By analyzing the temporal, spatial and population distribution, trend prediction and risk factor analysis of ischemic stroke worldwide based on GBD2021, we hope our study can provide reliable basis for national health policy makers to formulate targeted strategies.Our study provides targeted and innovative but fragmented recommendations for the prevention and treatment of stroke burden based on the latest GBD database. In order to make our guidance more comprehensive and systematic, we combined with the World Stroke Organization to summarize the recommendations of existing stroke guidelines for the management of stroke patients. The recommendations addressed pre-hospital, emergency, and acute hospital care. Strong recommendations were made for reperfusion therapies for acute ischemic stroke. For secondary prevention, strong recommendations included establishing etiological diagnosis; management of hypertension, weight, diabetes, lipids, and lifestyle modification; and for IS, management of atrial fibrillation, valvular heart disease, left ventricular and atrial thrombi, patent foramen ovale, atherosclerotic extracranial large vessel disease, intracranial atherosclerotic disease, and antithrombotics in noncardioembolic stroke. For rehabilitation, there were strong recommendations for organized stroke unit care, multidisciplinary rehabilitation, task-specific training, fitness training, and specific interventions for post-stroke impairments51.
Conclusion
This study covers countries and regions with different levels of social development around the world, covering a time span of more than 30 years. The epidemiological parameters of IS are comprehensively evaluated and analyzed from multiple levels, such as gender, age, and SDI, and the main risk factors are carefully stratified, and the possible causes of its distribution are analyzed at social and biological levels. It also provides guidance for national health policy-making.
Methods
Overview and case definition
The Global Burden of Disease 2021 study estimated the burden(e.g., incidence, death, and prevalence, DALYs) of 371 diseases and injuries and 88 risk factors from 1990 to 2021 in seven super-regions, 21 regions, 204 countries and territories(including 21 countries with subnational locations), and 811 subnational locations1,10. Detailed descriptions of the methodologies, reported fatal estimates, and reported nonfatal estimates are publicly available at https://vizhub.healthdata.org/gbd-compare/ 192 and https://ghdx.healthdata.org/gbd-results-tool.
Details of the GBD 2021 eligibility criteria, the literature search strategy, and data extraction are described in the Supplementary Methods section of the Supplementary Information. In the GBD 2021 dataset, ischemic stroke is defined according to the clinical criteria of the World Health Organization (WHO) as an episode of neurological dysfunction due to focal cerebral, spinal, or retinal infarction1,7,9,10. The different categories of ischemic stroke in the GBD 2021dataset are classified based on the International Classification of Diseases (ICD)−9 codes 433–435.9, 437.0–437.2, and 437.4–437.9, as well as the ICD-10 codes G45–G46.8, I63–I63.9, I65–I66.9, I67.2–I67.848, and I69.3–I69.411,7,9. Because this study was based on data from a public database and did not involve confidential information about human participants, the Ethics Committee of the Chinese People’s Liberation Army General Hospital deemed no ethical review was required.
Calculation model (VSports app下载)
The GBD 2021 employed standardized tools to model processed data, estimating epidemiological and burden parameters based on age, sex, location, and year. The three primary models used are the Cause of Death Ensemble Modeling (CODEm) framework, the DisMod-MR 2.1 (disease-model Bayesian meta-regression) tool, and spatiotemporal Gaussian process regression (ST-GPR)52. The comparative risk assessment framework of the GBD was applied to estimate the burden attributable to various risk factors. The theoretical minimum risk exposure level (TMREL) is defined as the level of exposure that minimizes risk across the population, serving as a counterfactual for comparisons. The attributable burden is the difference between the currently observed burden and the burden that would be observed if exposure levels were equal to the TMREL53.
VSports最新版本 - The sociodemographic index (SDI)
The Sociodemographic Index (SDI) is a composite indicator reflecting a country’s development level based on lag-distributed income per capita, average educational attainment for individuals over 15 years, and the total fertility rate for those under 25 years6. The SDI ranges from 0 (minimal development) to 1 (maximal development)53,54. Based on SDI values, the 204 countries and regions were categorized into five groups: high-SDI, medium-high-SDI, medium-SDI, medium-low-SDI, and low-SDI regions54.
World Bank Income Group Classification
Countries were classified by economic development according to the standard World Bank classification of economies (high-, upper-middle-, lower-middle-, and low-income countries)55.
Estimated annual percentage changes (EAPC)
We calculated the Estimated Annual Percentage Changes (EAPCs) in age-standardized rates of ischemic stroke to describe trends over specific time intervals. These EAPCs were determined using the regression model: Y = α + βX + ε, where Y represents the natural logarithm of the age-standardized rate, X is the calendar year, and ε is the error term8. Here, β represents the trend in the age-standardized rate. The natural logarithm of an age-standardized rate is assumed to be linear over time, with EAPC calculated as 100 × (exp(β) – 1). The 95% confidence interval (CI) of an EAPC is derived from this linear model2. If both the EAPC and the lower limit of its 95% CI are positive, the age-standardized rate is increasing; if both the EAPC and the upper limit of its 95% CI are negative, the rate is decreasing. Otherwise, the rate is considered stable2.
To examine the relationship between the ischemic stroke burden and SDI, we used data from 1990 to 2021 to conduct a frontier analysis based on age-standardized death rates (ASDR) and SDI, aiming to understand potential improvements in ischemic stroke DALYs that might be achieved in different countries or regions56,57.
Bayesian Age-Period-Cohort (BAPC)
In this study, we utilized a Bayesian age-period-cohort (BAPC) model with integrated nested Laplace approximations to project future trends in ischemic stroke burden. Previous research indicates that the BAPC model offers superior coverage and precision compared to alternative prediction methods58–61.
"V体育安卓版" Autoregressive Integrated Moving Average (ARIMA) model
To further validate the projections obtained using the Bayesian Age-Period-Cohort (BAPC) model, we employed the Autoregressive Integrated Moving Average (ARIMA) model, a widely used time series forecasting method. ARIMA was applied to the data from 1990 to 2021 to assess the consistency and reliability of the predicted trends for ischemic stroke incidence, prevalence, mortality, and DALYs. The ARIMA model was selected due to its capacity to model temporal dependencies and trends without requiring complex assumptions about underlying causal mechanisms62.
V体育2025版 - Statistic analysis
All charts were made by R software (version 4.3.2) (R Foundation for Statistical Computing, Vienna, Austria). P Values less than 0.05 were considered statistically significant.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Supplementary information
Description of Additional Supplementary Files
Acknowledgements
This work was supported by Noncommunicable Chronic Diseases-National Science and Technology Major Project (2023ZD0515900). The Bill and Melinda Gates Foundation, who were not involved in any way in the preparation of this manuscript, funded the Global Burden of Disease study. We would like to express our gratitude to the First Medical Center of the PLA General Hospital for its support for this research, and to Professor Li Xiru for his support for our research.
"VSports app下载" Abbreviations
- ASDR
 Age‑standardized death rate
- ASIR
 Age-standardized incidence rate
- ASPR
 Age-standardized prevalence rate
- ASR
 Age-standardized rate
- CI
 Confidence interval
- DALYs
 Disability‑adjusted life‑years
- EAPC
 Estimated annual percentage change
- GBD
 Global Burden of Disease Study
- ICD
 International Classification of Disease
- IS
 Ischemic stroke
- SDI
 Sociodemographic index
- UI
 Uncertainty interval
- YLD
 Years lived with disability
- YLL
 Years of life lost
VSports - Author contributions
Professor Jianning Zhang as a lead contact in this paper. J.Z., L.Z., G.W., and H.R. contributed equally as corresponding authors and conceptualized, designed, supervised, and guided the study. J.L., A.X., Z.Z., B.R., Z.G., and D.F. analyzed the data and performed statistical analyses. J.L., A.X., Z.Z., and Z.G. drafted the initial manuscript. D.F., B.H., J.S., X.B., L.M., X.Z., and Y.W. each contributed to the literature search, review, and revision of the manuscript.
Peer review
Peer review information (V体育ios版)
Communications Medicine thanks Michael Brainin, Charles D A Wolfe, and the other anonymous, reviewer(s) for their contribution to the peer review of this work. [A peer review file is available].
Data availability
The datasets generated and/or analyzed during the current study are available in the GBD 2021. Publicly available datasets were analyzed in the current study. The data can be found here: https://ghdx.healthdata.org/gbd-results-tool. Free user registration may be required to access certain datasets. The analyzed data will be shared upon reasonable request to the corresponding author. The numerical data underlying the figures are provided in the Supplementary Data files: The source data for Fig. 1 are in Supplementary Data 9. The source data for Fig. 2 are in Supplementary Data 10. The source data for Fig. 3 are in Supplementary Data 11. The source data for Fig. 4 are in Supplementary Data 12. The source data for Fig. 5 are in Supplementary Data 13. The source data for Fig. 6 are in Supplementary Data 14.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
These authors contributed equally: Jiayu Liu, Aoxi Xu, Zhifeng Zhao, Bin Ren, Zhao Gao, Dandong Fang.
Contributor Information
Hecheng Ren, Email: doctorrenhecheng@www.qiuluzeuv.cn.
Guan Wang, Email: neurocrown@www.qiuluzeuv.cn.
Li Zhu, Email: zhuxiaoli0430@www.qiuluzeuv.cn.
Jianning Zhang, Email: jnzhang2018@www.qiuluzeuv.cn.
Supplementary information
The online version contains supplementary material available at 10.1038/s43856-025-00939-y.
References
- 1.Ferrari, A. J. et al. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet403, 2133–2161 (2024). [DOI] [PMC free article] [PubMed]
 - 2.Ding, Q. et al. Global, regional, and national burden of ischemic stroke, 1990–2019. Neurology98, e279–e290 (2022). [DOI] [PubMed] [Google Scholar]
 - 3.Bennett, D. A. et al. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob. Heart9, 107–112 (2014). ["VSports手机版" DOI] [PubMed] [Google Scholar]
 - 4.Krishnamurthi, R. V. et al. Stroke prevalence, mortality and disability—adjusted life years in children and youth aged 0–19 years: data from the global and regional burden of stroke 2013. Neuroepidemiology45, 177–189 (2015). ["VSports app下载" DOI] [PubMed] [Google Scholar]
 - 5.Krishnamurthi, R. V. et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20–64 years in 1990–2013: data from the global burden of disease 2013 study. Neuroepidemiology45, 190–202 (2015). [DOI] [PubMed] [Google Scholar]
 - 6.Krishnamurthi, R. V., Ikeda, T. & Feigin, V. L. Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017. Neuroepidemiology54, 171–179 (2020). [DOI] [PubMed] [Google Scholar]
 - 7.Zhang, R. et al. Global burden of ischemic stroke in young adults in 204 countries and territories. Neurology100, e422–e434 (2023). [DOI] [PubMed] [Google Scholar]
 - 8.Zhang, L., Lu, H. & Yang, C. Global, regional, and national burden of stroke from 1990 to 2019: a temporal trend analysis based on the global burden of disease study 2019. Int. J. Stroke19, 686–694 (2024). [DOI] [PubMed] [Google Scholar]
 - 9.Feigin, V. L. et al. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Neurol.20, 795–820 (2021). [VSports最新版本 - DOI] [PMC free article] [PubMed]
 - 10.Naghavi, M. et al. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet403, 2100–2132 (2024). [DOI] [PMC free article] [PubMed]
 - 11.Feigin, V. L. et al. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol.23, 973–1003 (2024). [DOI] [PubMed]
 - 12.Bennett, D. A. Methodology of the global and regional burden of stroke study. Neuroepidemiology38, 30–40 (2012). [DOI] [PubMed] [Google Scholar]
 - 13.Boden-Albala, B. & Quarles, L. W. Education strategies for stroke prevention. Stroke44, S48–S51 (2013). [DOI] [PubMed] [Google Scholar]
 - 14.Kalkonde, Y. V., Alladi, S., Kaul, S. & Hachinski, V. Stroke prevention strategies in the developing world. Stroke49, 3092–3097 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 15.Marsh, J. D. & Keyrouz, S. G. Stroke prevention and treatment. J. Am. Coll. Cardiol.56, 683–691 (2010). [DOI] [PubMed] [Google Scholar]
 - 16.Straus, S. E., Majumdar, S. R. & McAlister, F. A. New evidence for stroke prevention: scientific review. JAMA288, 1388–1395 (2002). [DOI] [PubMed] [Google Scholar]
 - 17.Hill, V. A. & Towfighi, A. Modifiable risk factors for stroke and strategies for stroke prevention. Semin Neurol37, 237–258 (2017). [DOI] [PubMed] [Google Scholar]
 - 18.Feigin, V. L., Lawes, C. M. M., Bennett, D. A., Barker-Collo, S. L. & Parag, V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol.8, 355–369 (2009). [DOI (V体育官网入口)] [PubMed] [Google Scholar]
 - 19.Steinmetz, J. D. et al. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol.23, 344–381 (2024). [VSports app下载 - DOI] [PMC free article] [PubMed]
 - 20.Ge, R. et al. Global, regional, and national temporal trends of diet-related ischemic stroke mortality and disability from 1990 to 2019. Int. J. Stroke19, 665–675 (2024). ["V体育2025版" DOI] [PubMed] [Google Scholar]
 - 21.Kivimäki, M. et al. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study. Lancet Diabetes Endocrinol.6, 705–713 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 22.Khemraj, R. R., Solano, C., Patel, N. M. & Franklin, B. A. Impact of social disparities on cardiovascular disease and COVID-19 outcomes: barriers to care and preventive interventions. J. Cardiopulm. Rehabil. Prev.42, 84–89 (2022). [DOI] [PubMed] [Google Scholar]
 - 23.Giroud, M., Jacquin, A. & Béjot, Y. The worldwide landscape of stroke in the 21st century. Lancet383, 195–197 (2014). [DOI] [PubMed] [Google Scholar]
 - 24.Yu, C. et al. Sex differences in stroke subtypes, severity, risk factors, and outcomes among elderly patients with acute ischemic stroke. Front. Aging Neurosci.7, 174 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 25.Tikk, K. et al. Primary preventive potential for stroke by avoidance of major lifestyle risk factors: the European prospective investigation into cancer and nutrition-Heidelberg cohort. Stroke45, 2041–2046 (2014). [DOI] [PubMed] [Google Scholar]
 - 26.Yahya, T. et al. Stroke in young adults: current trends, opportunities for prevention and pathways forward. Am. J. Prev. Cardiol.3, 100085 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 27.Li, X.-Y. et al. Global, regional, and national burden of ischemic stroke, 1990–2021: an analysis of data from the global burden of disease study 2021. EClinicalMedicine75, 102758 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 28.Raskob, G. E. et al. Thrombosis: a major contributor to global disease burden. Arterioscler. Thromb. Vasc. Biol.34, 2363–2371 (2014). [DOI] [PubMed] [Google Scholar]
 - 29.Gullotta, G. S. et al. Age-induced alterations of granulopoiesis generate atypical neutrophils that aggravate stroke pathology. Nat. Immunol.24, 925–940 (2023). [DOI] [PubMed] [Google Scholar]
 - 30.Zhong, X., Sun, Y., Lu, Y. & Xu, L. Immunomodulatory role of estrogen in ischemic stroke: neuroinflammation and effect of sex. Front. Immunol.14, 1164258 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 31.Satue, E. et al. Incidence and risk conditions of ischemic stroke in older adults. Acta Neurol. Scand.134, 250–257 (2016). [DOI] [PubMed] [Google Scholar]
 - 32.Joseph, J., Koka, M. & Aronow, W. S. Prevalence of moderate and severe renal insufficiency in older persons with hypertension, diabetes mellitus, coronary artery disease, peripheral arterial disease, ischemic stroke, or congestive heart failure in an academic nursing home. J. Am. Med. Dir. Assoc.9, 257–259 (2008). ["V体育2025版" DOI] [PubMed] [Google Scholar]
 - 33.Isakadze, N. et al. Rationale and design of the mTECH-rehab randomized controlled trial: impact of a mobile technology-enabled corrie cardiac rehabilitation program on functional status and cardiovascular health. J. Am. Heart Assoc.13, e030654 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 34.Micha, R. et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA317, 912–924 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 35.Diener, H.-C. & Hankey, G. J. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage: JACC focus seminar. J. Am. Coll. Cardiol.75, 1804–1818 (2020). [DOI] [PubMed] [Google Scholar]
 - 36.Boehme, A. K., Esenwa, C. & Elkind, M. S. V. Stroke risk factors, genetics, and prevention. Circ. Res.120, 472–495 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 37.Martínez-González, M. A., Gea, A. & Ruiz-Canela, M. The Mediterranean diet and cardiovascular health. Circ. Res.124, 779–798 (2019). [DOI] [PubMed] [Google Scholar]
 - 38.Pase, M. P. et al. Sugar- and artificially sweetened beverages and the risks of incident stroke and dementia: a prospective cohort study. Stroke48, 1139–1146 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 39.Baden, M. Y. et al. Quality of plant-based diet and risk of total, ischemic, and hemorrhagic stroke. Neurology96, e1940–e1953 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 40.Hong, C. et al. Predictive accuracy of stroke risk prediction models across black and white race, sex, and age groups. JAMA329, 306–317 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 41.Madsen, T. E. Persistent disparities in recurrent ischemic stroke by race and geography in the US Medicare fee-for-service population. Stroke53, 3348–3349 (2022). [DOI] [PubMed] [Google Scholar]
 - 42.Leifheit, E. C., Wang, Y., Goldstein, L. B. & Lichtman, J. H. Trends in 1-year recurrent ischemic stroke in the US medicare fee-for-service population. Stroke53, 3338–3347 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 43.Albright, K. C. et al. Racial differences in recurrent ischemic stroke risk and recurrent stroke case fatality. Neurology91, e1741–e1750 (2018). [DOI (VSports在线直播)] [PMC free article] [PubMed] [Google Scholar]
 - 44.Madsen, T. E. et al. Sex and race differences in the risk of ischemic stroke associated with fasting blood glucose in REGARDS. Neurology97, e684–e694 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 45.Ibeh, C., Marshall, R. S. & Willey, J. Z. Race-ethnicity, age, and heart failure in ischemic stroke. J. Stroke Cerebrovasc. Dis.33, 107809 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 46.Sarfo, F. S. et al. Risk factor characterization of ischemic stroke subtypes among West Africans. Stroke53, 134–144 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 47.Akinyemi, R. O. et al. Novel functional insights into ischemic stroke biology provided by the first genome-wide association study of stroke in indigenous Africans. Genome Med.16, 25 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 48.Luo, Z. et al. Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021. EClinicalMedicine76, 102829 (2024). ["V体育官网入口" DOI] [PMC free article] [PubMed] [Google Scholar]
 - 49.Hou, S. et al. Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021. Eur. J. Neurol.31, e16481 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 50.Cheng, F. et al. Epidemiological trends and age-period-cohort effects on ischemic stroke burden across the BRICS-plus from 1992 to 2021. BMC Public Health25, 137 (2025). ["VSports" DOI] [PMC free article] [PubMed] [Google Scholar]
 - 51.Mead, G. E. et al. A systematic review and synthesis of global stroke guidelines on behalf of the World Stroke Organization. Int. J. Stroke18, 499–531 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 52.Wu, L. et al. Global, regional, and national burdens of mild traumatic brain injuries from 1990-2019: findings from the Global Burden of Disease Study 2019—a cross-sectional study. Int. J. Surg.111, 160–170 (2024). [DOI] [PMC free article] [PubMed]
 - 53.Rezaei, F., Mazidimoradi, A., Rayatinejad, A., Allahqoli, L. & Salehiniya, H. Temporal trends of tracheal, bronchus, and lung cancer between 2010 and 2019, in Asian countries by geographical region and sociodemographic index, comparison with global data. Thorac. Cancer14, 1668–1706 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 54.Lv, B. et al. Epidemiological trends of subarachnoid hemorrhage at global, regional, and national level: a trend analysis study from 1990 to 2021. Mil. Med. Res.11, 46 (2024). ["V体育官网" DOI] [PMC free article] [PubMed] [Google Scholar]
 - 55.Bernabe, E. et al. Global, regional, and national levels and trends in burden of oral conditions from 1990 to 2017: a systematic analysis for the Global Burden of Disease 2017 study. J. Dent. Res.99, 362–373 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 56.Xie, Y. et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int.94, 567–581 (2018). [DOI] [PubMed] [Google Scholar]
 - 57.Han, T., Chen, W., Qiu, X. & Wang, W. Epidemiology of gout—Global burden of disease research from 1990 to 2019 and future trend predictions. Ther. Adv. Endocrinol. Metab.15, 20420188241227295 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 58.Knoll, M. et al. An R package for an integrated evaluation of statistical approaches to cancer incidence projection. BMC Med. Res. Methodol.20, 257 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 59.Li, S. et al. Changing trends in the disease burden of esophageal cancer in China from 1990 to 2017 and its predicted level in 25 years. Cancer Med.10, 1889–1899 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 60.Liu, N. et al. Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea. BMC Cancer22, 826 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 61.Wu, B. et al. Temporal trends of breast cancer burden in the Western Pacific Region from 1990 to 2044: implications from the Global Burden of Disease Study 2019. J. Adv. Res.59, 189–199 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 - 62.Yu, Z. et al. Disease burden and attributable risk factors of lip and oral cavity cancer in China from 1990 to 2021 and its prediction to 2031. Front. Public Health12, 1419428 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
 
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Description of Additional Supplementary Files
Data Availability Statement
The datasets generated and/or analyzed during the current study are available in the GBD 2021. Publicly available datasets were analyzed in the current study. The data can be found here: https://ghdx.healthdata.org/gbd-results-tool. Free user registration may be required to access certain datasets. The analyzed data will be shared upon reasonable request to the corresponding author. The numerical data underlying the figures are provided in the Supplementary Data files: The source data for Fig. 1 are in Supplementary Data 9. The source data for Fig. 2 are in Supplementary Data 10. The source data for Fig. 3 are in Supplementary Data 11. The source data for Fig. 4 are in Supplementary Data 12. The source data for Fig. 5 are in Supplementary Data 13. The source data for Fig. 6 are in Supplementary Data 14.






